Aggregated price index with volume information
Summary:
- Medical/Nursing Services stocks down 0.1% on average while median return down -0.6% in a day
- Medical/Nursing Services stocks down -0.0% on average while median return down 0.5% in a week
- Medical/Nursing Services stocks down 6.7% on average while median return down 7.3% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $AMS 16.7%, $PDEX 7.6%, $PNTG 4.6%, $FMS 3.8%, $NTRA 1.3%
- 1M losers are : Losers for past month are $SMTI -13.8%, $BDSX -14.6%, $ACCD -20.9%, $CRDF -28.9%, $OPTN -42.1%
- 1W winners are : Winners for past week are $GH 8.0%, $NTRA 7.5%, $CSTL 5.5%, $AMS 5.0%, $ACHC 4.9%
- 1W losers are : Losers for past week are $SMTI -4.8%, $CRDF -6.0%, $CHE -6.7%, $BRTX -8.0%, $ACCD -13.5%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 11.9%, for the past 3 months is 8.0%
In the past month for a 5 days rolling window, the highest corrrelation is 24.9%, the lowest correlation is 1.9%, the latest correlation is 7.8%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 69.8% between AAC and OPTN
The lowest correlation is -60.3% between FLGT and GHSI
Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says
Option Care (OPCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Nearly 2.2 million devices are affected by the recall. Fresenius Medical Care will not have to remove products due to the issue.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is pleased to announce Scott Kahn, Ph.D. is joining the Board as a Class I Director. Dr. Kahn has a distinguished career in life sciences spending over 30 years in global leadership positions. Prior to starting his career in the life science industry, he was an assistant professor of organic chemistry at the
A week ago, Option Care Health, Inc. ( NASDAQ:OPCH ) came out with a strong set of first-quarter numbers that could...
Chemed Corporation ( NYSE:CHE ) shareholders are probably feeling a little disappointed, since its shares fell 4.0% to...
Q4 2024 Accolade Inc Earnings Call
Accolade Inc reports a significant 30% year-over-year revenue growth in Q4, alongside strategic expansions and performance insights.
Explore key insights from Chemed Corp's Q1 2024 earnings, including significant growth in VITAS services and challenges faced by Roto-Rooter.